Equity Research Medical Care Facilities

Should You Buy The Ensign Group, Inc. Stock in 2026?

By CirclFi Research Team · · 13/13 models active

According to the CirclFi Deep Alpha Valuation Engine, The Ensign Group, Inc. (ENSG) ranks in the top tier of our coverage universe with a Quality of Company score of 9.3/10. Trading at a market price of $171.28, this high-quality profile requires careful comparison against our 13 intrinsic value models.

The short answer: 3 of 13 CirclFi valuation models project upside for The Ensign Group, Inc. (ENSG) at $171.28 — the model consensus leans bearish, with a Quality Score of 9.3/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 10 of 13 models suggest overvaluation — majority bearish
  • Quality Score: 9.3/10 — Excellent — top-tier fundamentals
  • Value Trap Risk: 12/100 — Minimal — healthy fundamentals
  • Fair Value Range: $9.10 – $243.18 (2572% spread)

Bullish Models

3 / 13

Bearish Models

10 / 13

Quality Score

9.3 /10

Excellent — top-tier fundamentals

Value Trap Risk

12 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

13 /13
Active Models

Avg. confidence: 50%

Investment Thesis

The Bull Case

Target: $243.18 (+42.0% upside)

  • According to the CirclFi Quality of Company (QOC) framework, The Ensign Group, Inc.'s score of 9.3/10 reflects durable competitive advantages that should sustain earnings power through market cycles.
  • According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $243.18 (+42.0%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously.

The Bear Case

Target: $9.10 (-94.7%)

  • According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model sees the stock as overvalued with a fair value of $9.10 (-94.7%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +136.7% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.

Peer Benchmarking

ADUS Addus HomeCare Corpo
9.7
PNTG The Pennant Group, I
9.3
ARDT Ardent Health, Inc.
9.1
CHE Chemed Corp
9.1
UHS Universal Health Ser
9.0

See full Medical Care Facilities rankings →

Valuation Divergence

Spread

2572%

Fair Value Range

$9.10 – $243.18

A 2572% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

First Chicago

$243.18 (+42.0%)

Most Bearish

Markov DDM

$9.10 (-94.7%)

Key Risk Factors

Model Disagreement

2572% spread signals high variance in projections.

Bearish Consensus

10/13 models suggest overvaluation.

Macro/Sector Risk

Medical Care Facilities headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View ENSG Data Page →

The Bottom Line

Our valuation engine sends a clear cautionary signal on The Ensign Group, Inc. at $171.28. 10/13 models flag overvaluation, composite fair value sits at $108.05 (-36.9%), and the risk-reward profile appears unfavorable. Quality at 9.3/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. The Ensign Group, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy ENSG stock right now?

Based on CirclFi's multi-model analysis, 3 of 13 models see upside for ENSG at $171.28. The models are divided, which means the investment case depends heavily on your assumptions about The Ensign Group, Inc.'s future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in The Ensign Group, Inc.?

Key risks include: wide model disagreement (2572% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.

How does ENSG compare to its competitors?

Among Medical Care Facilities peers, ENSG holds a Quality Score of 9.3/10. Comparable companies include ADUS (QOC 9.7), PNTG (QOC 9.3), ARDT (QOC 9.1). The relative ranking helps investors identify whether ENSG offers better fundamental quality than alternatives in the same sector.

Is ENSG a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ENSG's Quality Score of 9.3/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy ENSG at?

CirclFi does not provide target buy prices or price alerts. However, our 13 active models produce fair value estimates ranging from $9.10 to $243.18. At $171.28, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for ENSG.

View ENSG Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →